S&P 500
6,025.16
+0.3%
+$19.28
DJI
42,835.04
+0.2%
+$73.28
NASDAQ
19,637.20
+0.2%
+$45.96
Bitcoin
108,771.00
+0.4%
+451.37
AAPL
$201.81
+0.2%
+$0.36
AMZN
$215.93
-0.5%
-$1.05
GOOG
$180.62
+1.7%
+$2.99
META
$697.17
+0.4%
+$3.11
MSFT
$469.23
-0.7%
-$3.52
NVDA
$142.70
+0.0%
+$0.07
TSLA
$320.69
+3.9%
+$12.11
Adicet Bio (NASDAQ: ACET)
$0.78
(1.6%)
$0.01
Price as of June 10, 2025, 1:36 p.m. ET
Adicet Bio Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Adicet Bio Company Info
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
News & Analysis
Featured Article
3 Biotech Stocks That Could Make You Richer in February (and Beyond)
These companies' share prices could rise in the short term, but their long-term opportunities are even better.
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Feb 5, 2022
Featured Article
3 Biotech Stocks That Could Double in 2022
They're risky. But with the high risk comes the potential for high rewards.
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Jan 3, 2022
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.